• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于食管癌诊断的唾液来源外泌体蛋白质组和脂质组的综合分析

Integrative analysis of saliva-derived exosomal proteome and lipidome for the diagnosis of esophageal squamous cell carcinoma.

作者信息

Zhong Wei, Liu Jian, Xie Junhua, Zhang Zhiyan, Gong Zhiwen, Yan Zhixiang, Cao Qingdong

机构信息

Department of Thoracic Surgery and Lung Transplantation, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, 519000, China.

Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, 519000, China.

出版信息

BMC Cancer. 2025 Aug 1;25(1):1254. doi: 10.1186/s12885-025-14452-x.

DOI:10.1186/s12885-025-14452-x
PMID:40751234
Abstract

BACKGROUND

Early diagnosis of esophageal squamous cell carcinoma (ESCC) is crucial for improving patient prognosis. Currently, the diagnosis of ESCC primarily relies on endoscopic biopsy. Salivary exosomes have shown great potential in non-invasive screening, but their proteomic and lipidomic characteristics remain to be reported.

METHODS

Exosomes were isolated from salivary samples of 54 patients with ESCC and 62 healthy controls using ultracentrifugation, and subsequently subjected to non-targeted proteomic and lipidomic analysis by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Differentially expressed proteins and lipids in salivary exosomes were identified through differential analysis, and a comprehensive analysis of multi-omics data was performed using correlation analysis.

RESULTS

Significant proteomic and lipidomic differences were observed between ESCC patients and healthy controls. The proteomic characteristics of ESCC were primarily manifested in immune responses, disruption of tissue structural homeostasis, and enhanced antifungal and antimicrobial humoral immune responses. Through multi-omics analysis, we found that ESCC may regulate fatty acid metabolism by modulating epigenetic modifications, thereby influencing the oral immune microenvironment. Finally, a diagnostic model constructed using 28 lipid features achieved excellent diagnostic performance (Are Under the Curve = 1.000) for ESCC diagnosis.

CONCLUSIONS

Our study revealed significant alterations in the proteomic and lipidomic profiles of the oral microenvironment in ESCC patients, which may provide new insights into the development and progression of ESCC. We found that lipid features have high potential for diagnosing ESCC, providing support for further validation in larger cohorts.

摘要

背景

食管鳞状细胞癌(ESCC)的早期诊断对于改善患者预后至关重要。目前,ESCC的诊断主要依赖于内镜活检。唾液外泌体在无创筛查中显示出巨大潜力,但其蛋白质组学和脂质组学特征仍有待报道。

方法

采用超速离心法从54例ESCC患者和62例健康对照者的唾液样本中分离外泌体,随后通过液相色谱-串联质谱(LC-MS/MS)进行非靶向蛋白质组学和脂质组学分析。通过差异分析鉴定唾液外泌体中差异表达的蛋白质和脂质,并使用相关性分析对多组学数据进行综合分析。

结果

ESCC患者与健康对照者之间存在显著的蛋白质组学和脂质组学差异。ESCC的蛋白质组学特征主要表现在免疫反应、组织结构稳态破坏以及抗真菌和抗菌体液免疫反应增强。通过多组学分析,我们发现ESCC可能通过调节表观遗传修饰来调控脂肪酸代谢,从而影响口腔免疫微环境。最后,利用28个脂质特征构建的诊断模型对ESCC诊断具有出色的诊断性能(曲线下面积=1.000)。

结论

我们的研究揭示了ESCC患者口腔微环境蛋白质组学和脂质组学谱的显著改变,这可能为ESCC的发生和发展提供新的见解。我们发现脂质特征在诊断ESCC方面具有很高的潜力,为在更大队列中进行进一步验证提供了支持。

相似文献

1
Integrative analysis of saliva-derived exosomal proteome and lipidome for the diagnosis of esophageal squamous cell carcinoma.用于食管癌诊断的唾液来源外泌体蛋白质组和脂质组的综合分析
BMC Cancer. 2025 Aug 1;25(1):1254. doi: 10.1186/s12885-025-14452-x.
2
Plasma-derived Exosomal miR-25-3p and miR-23b-3p as Predictors of Response to Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.血浆衍生外泌体 miR-25-3p 和 miR-23b-3p 作为预测食管鳞癌放化疗反应的标志物。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241289520. doi: 10.1177/15330338241289520.
3
Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinoma.由超级增强子驱动基因编码的分泌蛋白可能是早期检测食管鳞状细胞癌的有前途的生物标志物。
Biomed J. 2024 Aug;47(4):100662. doi: 10.1016/j.bj.2023.100662. Epub 2023 Sep 27.
4
Development a glycosylated extracellular vesicle-derived miRNA Signature for early detection of esophageal squamous cell carcinoma.开发一种用于早期检测食管鳞状细胞癌的糖基化细胞外囊泡衍生的微小RNA特征。
BMC Med. 2025 Jan 23;23(1):39. doi: 10.1186/s12916-025-03871-z.
5
ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles.ESCCPred:一种基于自身抗体谱的早期食管鳞状细胞癌诊断预测的机器学习模型。
Br J Cancer. 2024 Sep;131(5):883-894. doi: 10.1038/s41416-024-02781-w. Epub 2024 Jul 2.
6
Identification of CTSC-driven progression in ESCC by single-cell sequencing and experimental validation.通过单细胞测序和实验验证鉴定CTSC驱动的食管鳞状细胞癌进展
Front Immunol. 2025 Jul 16;16:1585139. doi: 10.3389/fimmu.2025.1585139. eCollection 2025.
7
Single-Cell Transcriptomics Reveals STAT1 Drives LHPP Downregulation in Esophageal Squamous Cell Carcinoma Progression.单细胞转录组学揭示 STAT1 驱动食管鳞癌进展中 LHPP 的下调。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241293485. doi: 10.1177/15330338241293485.
8
PANoptosis-driven molecular stratification in esophageal squamous cell carcinoma: A multi-omics prognostic model and FGFR-Targeted therapeutic validation.食管鳞状细胞癌中PAN细胞焦亡驱动的分子分层:一种多组学预后模型及FGFR靶向治疗验证
Comput Biol Med. 2025 Sep;196(Pt A):110688. doi: 10.1016/j.compbiomed.2025.110688. Epub 2025 Jul 8.
9
PYGB targeted by androgen receptor contributes to tumor progression and metabolic reprogramming in esophageal squamous carcinoma.雄激素受体靶向 PYGB 促进食管鳞癌的肿瘤进展和代谢重编程。
Cell Signal. 2024 Dec;124:111481. doi: 10.1016/j.cellsig.2024.111481. Epub 2024 Oct 21.
10
Single-cell proteomics analysis of human oocytes during GV-to-MI transition.人卵母细胞从生发泡期到第一次减数分裂中期转变过程中的单细胞蛋白质组学分析
Hum Reprod. 2025 May 13. doi: 10.1093/humrep/deaf086.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Fatty acid metabolism of immune cells: a new target of tumour immunotherapy.免疫细胞的脂肪酸代谢:肿瘤免疫治疗的新靶点。
Cell Death Discov. 2024 Jan 20;10(1):39. doi: 10.1038/s41420-024-01807-9.
3
Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study.
唾液细胞外 microRNAs 用于食管癌的早期检测和预后:一项临床研究。
Gastroenterology. 2023 Oct;165(4):932-945.e9. doi: 10.1053/j.gastro.2023.06.021. Epub 2023 Jul 1.
4
Impaired histone inheritance promotes tumor progression.染色质遗传缺陷促进肿瘤进展。
Nat Commun. 2023 Jun 10;14(1):3429. doi: 10.1038/s41467-023-39185-y.
5
Histone modifications in fat metabolism and obesity.脂肪代谢和肥胖中的组蛋白修饰。
Prog Mol Biol Transl Sci. 2023;197:135-152. doi: 10.1016/bs.pmbts.2023.01.003. Epub 2023 Feb 10.
6
Triglyceride cycling enables modification of stored fatty acids.甘油三酯循环使储存的脂肪酸能够被修饰。
Nat Metab. 2023 Apr;5(4):699-709. doi: 10.1038/s42255-023-00769-z. Epub 2023 Apr 3.
7
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.肿瘤进展和免疫逃逸中的细胞外基质重塑:从机制到治疗。
Mol Cancer. 2023 Mar 11;22(1):48. doi: 10.1186/s12943-023-01744-8.
8
The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020.2020年食管鳞状细胞癌和食管腺癌发病率及死亡率的全球格局以及至2040年的预测:来自GLOBOCAN 2020的新估计
Gastroenterology. 2022 Sep;163(3):649-658.e2. doi: 10.1053/j.gastro.2022.05.054. Epub 2022 Jun 4.
9
A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study.基于 microRNA 的液体活检标志物用于食管鳞癌的早期检测:一项回顾性、前瞻性和多中心研究。
Mol Cancer. 2022 Feb 11;21(1):44. doi: 10.1186/s12943-022-01507-x.
10
Characterizing and exploiting the many roles of aberrant H2B monoubiquitination in cancer pathogenesis.描述和利用异常 H2B 单泛素化在癌症发病机制中的多种作用。
Semin Cancer Biol. 2022 Nov;86(Pt 3):782-798. doi: 10.1016/j.semcancer.2021.12.007. Epub 2021 Dec 22.